Late COVID treatment may still benefit at-risk patients
A study offers new information about late-onset treatment introduced 14 days after infection with SARS-CoV-2, the virus that causes COVID-19.
Link :
https://www.futurity.org/late-covid-treatment-immunocompromised-patients-3247182/?utm_source=rss&utm_medium=rss&utm_campaign=late-covid-treatment-immunocompromised-patients-3247182
Link :
https://www.futurity.org/late-covid-treatment-immunocompromised-patients-3247182/?utm_source=rss&utm_medium=rss&utm_campaign=late-covid-treatment-immunocompromised-patients-3247182